Renal Transplant Rejection
📧 Sign up to get email alerts when something new happens for Renal Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant [Phase 2]
A Phase 2 trial comparing Siplizumab with Rabbit anti-thymocyte globulin to help kidney transplant acceptance; the study is not yet recruiti…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Deep Phenotyping of the Renal Allograft to Prognosticate Clinical Outcomes
A University of Pittsburgh-led clinical study aims to deeply phenotype renal allografts to prognosticate outcomes after kidney transplantati…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: VIRTUUS Children's Study
The VIRTUUS Children's Study (NCT03719339) sponsored by Children's Hospital of Philadelphia is currently active but not recruiting, focusing…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Multi-Parametric MRI for Renal Transplantation
This clinical trial update describes a study evaluating multi-parametric MRI for assessing renal transplant rejection.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Urine CXCL10 Monitoring Trial in Kidney Transplant [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/3 study evaluating urine CXCL10 monitoring in kidney transplant patients to help detect or pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA
A clinical trial update examining whether peripheral blood cell-free DNA can eliminate the need for pancreas biopsy in transplant patients, …
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating fostamatinib for chronic active antibody-mediated rejection in renal transplant patients is currently …
-
CLINICAL_TRIALS research · 2015-07-03Clinical Trial Update: A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death [Phase 1]
Phase 1 multicenter study evaluating whether mesenchymal stem cells can prevent rejection after kidney transplantation from donation after c…